|
|
| | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine Basic information |
| Product Name: | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine | | Synonyms: | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine;N-FMoc-N-benzyl-glycine;2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(benzyl)amino)acetic acid;Fmoc-N-benzylglycine≥ 99% (HPLC);N-α-(9-Fluorenylmethoxycarbonyl)-N-α-benzyl-glycine;Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-(phenylmethyl)-;2-[benzyl({[(9H-fluoren-9-yl)methoxy]carbonyl})amino]acetic acid | | CAS: | 141743-13-7 | | MF: | C24H21NO4 | | MW: | 387.43 | | EINECS: | | | Product Categories: | | | Mol File: | 141743-13-7.mol |  |
| | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine Chemical Properties |
| Boiling point | 604.0±44.0 °C(Predicted) | | density | 1.285±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,2-8°C | | pka | 3.89±0.10(Predicted) |
| | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine Usage And Synthesis |
| Chemical Properties | Colorless to white crystals powder | | Uses | Fmoc-?N-?benzylglycine is a reactant used in the solid phase synthesis of peptides. It was used in the synthesis of endomorphin 1 and 2 peptoid-peptide hybrids. Fmoc-?N-?benzylglycine was also used in the synthesis of human neuropeptide-S analogs modified in position 2. |
| | NALPHA-9-Fluorenylmethoxycarbonyl-N-benzylglycine Preparation Products And Raw materials |
|